[
  {
    "ts": null,
    "headline": "Intuitive Surgical AI Push And Global Expansion Tested By Rich Valuation",
    "summary": "Intuitive Surgical is integrating artificial intelligence into its robotic surgery systems across its platforms. The company reports strong global procedure volumes and continued growth in minimally invasive surgery adoption. Recent investments are focused on expanding direct operations and deepening its presence in key European markets. For investors watching NasdaqGS:ISRG, the story is not just about surgical robots; it is about how those systems are being upgraded with AI and scaled...",
    "url": "https://finnhub.io/api/news?id=e1c20329a874902eec4ef0c213e4a66719caf3f878bf57f175069fcbd5868376",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771276259,
      "headline": "Intuitive Surgical AI Push And Global Expansion Tested By Rich Valuation",
      "id": 139117485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical is integrating artificial intelligence into its robotic surgery systems across its platforms. The company reports strong global procedure volumes and continued growth in minimally invasive surgery adoption. Recent investments are focused on expanding direct operations and deepening its presence in key European markets. For investors watching NasdaqGS:ISRG, the story is not just about surgical robots; it is about how those systems are being upgraded with AI and scaled...",
      "url": "https://finnhub.io/api/news?id=e1c20329a874902eec4ef0c213e4a66719caf3f878bf57f175069fcbd5868376"
    }
  },
  {
    "ts": null,
    "headline": "CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT",
    "summary": "CDNA shares climb after AlloHeme data show early AML/MDS relapse detection, backing its Transplant+ expansion into cell therapy markets.",
    "url": "https://finnhub.io/api/news?id=44e6247c77bd0961dd4ca5ad1aaf476de33099becc08bdf96327b6275b9b9d4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771259520,
      "headline": "CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT",
      "id": 139116695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "CDNA shares climb after AlloHeme data show early AML/MDS relapse detection, backing its Transplant+ expansion into cell therapy markets.",
      "url": "https://finnhub.io/api/news?id=44e6247c77bd0961dd4ca5ad1aaf476de33099becc08bdf96327b6275b9b9d4e"
    }
  },
  {
    "ts": null,
    "headline": "TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial",
    "summary": "TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.",
    "url": "https://finnhub.io/api/news?id=be142bdd2d30cb6d3e3ed7005b2b2c1f5403052ea3f4f6e7ccc7a1c2278c1b77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771257120,
      "headline": "TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial",
      "id": 139115812,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.",
      "url": "https://finnhub.io/api/news?id=be142bdd2d30cb6d3e3ed7005b2b2c1f5403052ea3f4f6e7ccc7a1c2278c1b77"
    }
  },
  {
    "ts": null,
    "headline": "My 1 Top AI Healthcare Stock to Buy and Hold Forever",
    "summary": "The stock has averaged annual gains of nearly 25% over the past decade.",
    "url": "https://finnhub.io/api/news?id=e4103044a0a7e0824a845033a1ddff6a35f27ec00d03ab40837e88c0f10670ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771253820,
      "headline": "My 1 Top AI Healthcare Stock to Buy and Hold Forever",
      "id": 139114908,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "The stock has averaged annual gains of nearly 25% over the past decade.",
      "url": "https://finnhub.io/api/news?id=e4103044a0a7e0824a845033a1ddff6a35f27ec00d03ab40837e88c0f10670ef"
    }
  },
  {
    "ts": null,
    "headline": "1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Question",
    "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
    "url": "https://finnhub.io/api/news?id=e46dbd64a21d0e34ad2914ad1cdf550bb77803776412cf18902b3002f813d772",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771216783,
      "headline": "1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Question",
      "id": 139116696,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
      "url": "https://finnhub.io/api/news?id=e46dbd64a21d0e34ad2914ad1cdf550bb77803776412cf18902b3002f813d772"
    }
  }
]